For the best experience, open
on your mobile browser.

Niramai expands its presence by launching their breast screening facility in Kerala

05:51 PM Sep 20, 2022 IST | Charu Singh
niramai expands its presence by launching their breast screening facility in kerala


Bengaluru/ Kochi, 20 September, 2022: The first installation of Niramai’s Artificial Intelligence-based Thermalytix solution for early detection of breast cancer was launched in Kerala on Friday 16 September 2022. The Founder & CEO of NIRAMAI Health Analytix Dr. Geetha Manjunath who developed this innovative technology inaugurated the 1st Center in Kerala at Keyhole Clinic, Edapally, Kochi along with leading doctors from Kerala, Dr. R Padmakumar, Dr. Madhukar Pai, Dr. Arun Warrier, Dr. Maria Varghese and Dr. Mabel V Periera.

Breast Cancer is the leading cause of cancer deaths in women today. One in 17 women develop some form of breast problem in their lifetime and early detection is the key to survival. Niramai has developed a novel artificial intelligence-based medical device to detect breast cancer at a much earlier stage than traditional methods or self-examination. Niramai’s innovative solution called ‘Thermalytix’, is an automated breast health screening and diagnostic tool, which combines thermal imaging with artificial intelligence. NIRAMAI Thermalytix test can be done for women of 18 years and above. It is privacy-sensitive, non-invasive, radiation-free, and has high accuracy which can detect the minutest of lumps or other abnormalities. Women can avail of this service with a prior appointment.


Dr. Geetha Manjunath, Founder & CEO, Niramai Health Analytix, added, “We are excited to partner with Keyhole Clinic to take our clinically proven Thermalytix screening service to many more women in Kerala and help save lives. We are also conducting many free programs to raise awareness amongst women about early detection of breast cancer and educating the masses on the importance of frequent checks.”

Dr R Padmakumar, CMD of Keyhole Clinic, said, “We are committed to offering the best healthcare services to the general public. Collaborating with an innovative company like Niramai to offer early-stage breast screening will surely be beneficial to our patients.” Discounts for Niramai Breast screening in the month of September in connection with the launch and in October in connection with Breast Cancer Awareness Month were also announced by the team.

A CME on this novel technology was held during the occasion to learn more about this unique modality and how its no-touch, no-see, and no-radiation screening can encourage women of all ages to get tested. Dr. R Padmakumar, Dr. Madhukar Pai, Dr. Arun Warrier, Dr. Maria Varghese, and Dr. Mabel V Periera who chaired the CME spoke on the occasion and appreciated the efforts of Niramai in developing this technology which can save many lives.


About Niramai Health Analytix:

NIRAMAI Health Analytix is a deep-tech healthcare company offering a novel Artificial Intelligence-based, radiation-free, non-touch, highly accurate, breast cancer screening test for women of all age groups. The solution is portable, automated, and detects breast cancer at a much earlier stage than traditional screening methods. Their innovative solution called Thermalytix™ uses a high-resolution thermal sensing device and a cloud-hosted analytics solution for analyzing breast thermal images. NIRAMAI has conducted over 55,000 screenings so far and has over 100 installations at hospitals and diagnostic centers across 16 Indian cities. NIRAMAI has partnered with reputed diagnostic chains in India such as Apollo Clinics, Healthians, Ikigai, Health spring, HCG Cancer Hospitals among others.

NIRAMAI has received US FDA clearance for their first device called SMILE-100 System, the first Indian company to get an US FDA clearance for a medical device used for women’s health. They have also received regulatory clearance for Europe with a CE Mark Approval in addition to ISO 13485 and MDSAP (Medical Device Single Audit Program) International Certifications. NIRAMAI’s solution has led to 26 granted patents with 10 US patents and others across India, Singapore, China, and Canada. Their novel algorithms have also been peer-reviewed in international scientific conferences. NIRAMAI is the only Indian company listed on the 2019 cohort of AI 100 startups in the world by global business data intelligence platform CB Insights.

NIRAMAI has won some prestigious awards including Global Women’s Health Tech Award by World Bank and IFC in 2022, National Startup Award 2020 in India, and the Gold prize in Hack Osaka 2019 in Japan and was the winner of BNP Paribas Call4Ideas in Italy. They were also the winners of the Accenture AI award, Aegis GrahamBell Award, Amazon AI Award and are part of the NVidia Inception program. NIRAMAI was also accelerated at Google launchpad in San Francisco and has received research funding from the Bill & Melinda Gates Foundation and CDC UK.

NIRAMAI was co-founded in July 2016 by Dr. Geetha Manjunath and Ms Nidhi Mathur. NIRAMAI has so far raised a total of $7M from institutional investors from India, Japan and Singapore. Investors include Dream Incubator, BeeNext,  pi Ventures, Ankur Capital, Axilor Ventures, 500 Startups, and Flipkart co-founder Binny Bansal.


Tags :